© 2020 – 2023 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
News

‘Gamechanging’ breast cancer pill to be offered on NHS in England and Wales

U-turn by medicines watchdog means about 3,000 women with advanced forms of disease could benefit each year

Thousands of women with advanced breast cancer in England and Wales are to be offered a “gamechanging” twice-a-day pill on the NHS after a U-turn by the medicines watchdog.

Experts hailed the decision as a “landmark moment”. As many as 3,000 women every year could benefit from capivasertib for hormone receptor (HR)-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Continue reading…

Related posts

‘They’ve gone through hell’: fears for British prisoners of war in Ukraine

AEA3

Refugee group warns of ‘astonishing’ cost of new Home Office policies

AEA3

Israel launches strikes on ‘dozens’ of targets in Iran, targeting nuclear programme

AEA3

Pin It on Pinterest

Share This